Psychemedics Retained Earnings (Accumulated Deficit) 2010-2024 | PMD

Psychemedics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Psychemedics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-17
2022 $-12
2021 $-10
2020 $-9
2019 $-4
2018 $-1
2017 $-2
2016 $-5
2015 $-8
2014 $-7
2013 $-7
2012 $-7
2011 $-7
2010 $-8
2009 $-8
Psychemedics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-19
2024-06-30 $-18
2024-03-31 $-17
2023-12-31 $-17
2023-09-30 $-16
2023-06-30 $-14
2023-03-31 $-13
2022-12-31 $-12
2022-09-30 $-11
2022-06-30 $-10
2022-03-31 $-10
2021-12-31 $-10
2021-09-30 $-8
2021-06-30 $-8
2021-03-31 $-9
2020-12-31 $-9
2020-09-30 $-8
2020-06-30 $-7
2020-03-31 $-5
2019-12-31 $-4
2019-09-30 $-2
2019-06-30 $-2
2019-03-31 $-2
2018-12-31 $-1
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-4
2016-12-31 $-5
2016-09-30 $-6
2016-06-30 $-8
2016-03-31 $-9
2015-12-31 $-8
2015-09-30 $-8
2015-06-30 $-8
2015-03-31 $-7
2014-12-31 $-7
2014-09-30 $-6
2014-06-30 $-7
2014-03-31 $-7
2013-12-31 $-7
2013-09-30 $-7
2013-06-30 $-7
2013-03-31 $-7
2012-12-31 $-7
2012-09-30 $-7
2012-06-30 $-7
2012-03-31 $-7
2011-12-31 $-7
2011-09-30 $-7
2011-06-30 $-7
2011-03-31 $-8
2010-12-31 $-8
2010-09-30 $-8
2010-06-30 $-8
2010-03-31 $-8
2009-12-31 $-8
2009-09-30 $-8
2009-06-30 $-8
2009-03-31 $-7
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
Quest Diagnostics (DGX) United States $18.293B 18.54
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Chemed (CHE) United States $8.477B 26.05
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
Amedisys (AMED) United States $2.953B 21.02
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Atai Life Sciences (ATAI) Germany $0.255B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00